We find that patients with CTCL are at increased risk of second malignancies, especially Hodgkin and non-Hodgkin lymphoma, lung cancer, bladder cancer...
Despite disparities in trial participation and chemotherapy doses, outcomes did not differ by LOC suggesting that AYA with bone tumors can be treated...
Sono stati esaminati in modo retrospettivo 37 pazienti sottoposti a metastasectomia dei noduli polmonari sviluppatisi da osteosarcoma o da sarcoma dei...
Prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects contributing to functional impairment and disability in HL...